BDSX vs LRCX · rev $52.4M vs P/E 71, rev $23.23B
Biodesix Inc (BDSX) versus Lam Research Corp (LRCX) — a side-by-side from cached financials, not a winner call.
Biodesix Inc (BDSX) is a diagnostics & research company listed on NASDAQ.
Lam Research Corp (LRCX) is a semiconductor equipment & materials company listed on NASDAQ. It is led by Timothy M. Archer.
Latest reported BDSX revenue for 2026-06-30 was $52.4M. Net income was -$15.1M. BDSX currently screens at market cap $157.6M.
Latest reported LRCX revenue for 2026-06-28 was $23.23B. Net income was $7.27B. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
BDSX currently screens at market cap $157.6M. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
Not investment advice. Open the BDSX and LRCX stock pages for the full models.
Not investment advice.